Cite
HARVARD Citation
Kalantar-Zadeh, K. et al. (n.d.). FP330APABETALONE, A SELECTIVE BROMODOMAIN AND EXTRA-TERMINAL (BET) PROTEIN INHIBITOR, REDUCES SERUM FGF23 IN CARDIOVASCULAR DISEASE AND CHRONIC KIDNEY DISEASE PATIENTS. Nephrology dialysis transplantation. p. . [Online].